Clinical Trial Update: Candesartan Cilexetil + Chlorthalidone + Amlodipine Versus Exforge HCT®️ for Systemic Arterial Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing candesartan cilexetil + chlorthalidone + amlodipine versus Exforge HCT for hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Candesartan cilexetil + chlorthalidone + amlodipine
• Exforge HCT (amlodipine/valsartan/hydrochlorothiazide)

Snippet

Sponsor: Hospital Israelita Albert Einstein | Conditions: Hypertension | Phase 3 | Status: COMPLETED